Published in J Rheumatol Suppl on July 01, 2012
Abatacept as a successful therapy for myositis—a case-based review. Clin Rheumatol (2014) 0.89
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis. PLoS One (2014) 0.82
Emerging therapies for noninfectious uveitis: what may be coming to the clinics. J Ophthalmol (2014) 0.80
Characterization of T cell phenotype and function in a double transgenic (collagen-specific TCR/HLA-DR1) humanized model of arthritis. Arthritis Res Ther (2014) 0.79
Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis. Biomed Res Int (2014) 0.76
Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis. Inflammation (2015) 0.75
The pathophysiology of osteoarthritis. Aging Clin Exp Res (2003) 1.55
Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritis. Clin Exp Rheumatol (2011) 1.47
Serum amyloid-A in Behçet's disease. Clin Rheumatol (2014) 1.47
Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register). Ann Rheum Dis (2013) 1.44
Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study. J Rheumatol (2007) 1.34
Obesity and reduction of the response rate to anti-tumor necrosis factor α in rheumatoid arthritis: an approach to a personalized medicine. Arthritis Care Res (Hoboken) (2013) 1.29
Etanercept maintains the clinical benefit achieved by infliximab in patients with rheumatoid arthritis who discontinued infliximab because of side effects. Ann Rheum Dis (2006) 1.16
Longterm retention of tumor necrosis factor-α inhibitor therapy in a large italian cohort of patients with rheumatoid arthritis from the GISEA registry: an appraisal of predictors. J Rheumatol (2012) 1.02
Safety of anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis and chronic hepatitis C virus infection. J Rheumatol (2008) 1.00
Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. Autoimmun Rev (2012) 0.92
Improvement of renal function and disappearance of hepatitis B virus DNA in a patient with rheumatoid arthritis and renal amyloidosis following treatment with infliximab. Arthritis Rheum (2005) 0.91
Use of etanercept in the treatment of dermatomyositis: a case series. J Rheumatol (2006) 0.89
Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum (2005) 0.89
Laser-evoked potentials habituation in fibromyalgia. J Pain (2010) 0.88
Old and new antirheumatic drugs and the risk of hepatotoxicity. Ther Drug Monit (2012) 0.87
Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid. Rheumatology (Oxford) (2009) 0.87
Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features. J Neurol (2013) 0.85
Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study. J Rheumatol (2005) 0.84
Microscopic polyangiitis associated with primary biliary cirrhosis. J Rheumatol (2003) 0.84
The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertension. Curr Med Res Opin (2005) 0.84
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature. Clin Rheumatol (2014) 0.83
High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register. Clin Rheumatol (2013) 0.82
Chemerin/ChemR23 pathway: a system beyond chemokines. Arthritis Res Ther (2011) 0.81
Putative Role of Serum Amyloid-A and Proinflammatory Cytokines as Biomarkers for Behcet's Disease. Medicine (Baltimore) (2015) 0.81
Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab. Clin Rheumatol (2014) 0.80
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial. J Rheumatol (2014) 0.78
Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa. Medicine (Baltimore) (2015) 0.77
Functional impairments of microcirculation in HIV-positive patients: a laser Doppler fluxometry-based investigation. HIV Clin Trials (2009) 0.77
Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: analytical performance and clinical correlations. Clin Chim Acta (2005) 0.77
Gastrointestinal symptoms and motility disorders in patients with systemic scleroderma. BMC Gastroenterol (2008) 0.77
Remission in early, aggressive rheumatoid arthritis: a multicentre prospective observational Italian study ARPA (Artrite Reumatoide Precoce Aggressiva). Clin Exp Rheumatol (2013) 0.76
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response. Drug Dev Res (2014) 0.76
Human immunodeficiency virus-1 and rheumatoid arthritis: a puzzling association. J Rheumatol (2003) 0.75
Extracorporeal shock waves down-regulate the expression of interleukin-10 and tumor necrosis factor-alpha in osteoarthritic chondrocytes. BMC Musculoskelet Disord (2008) 0.75
Digital laser doppler flowmetry may discriminate "limited" from "diffuse" systemic sclerosis. Microvasc Res (2010) 0.75
Phenotype of chondrocytes in osteoarthritis. Biorheology (2008) 0.75
Efficacy and safety of certolizumab pegol in rheumatoid arthritis: meeting rheumatologists' requirements in routine clinical practice. BioDrugs (2014) 0.75
Recovery of barium swallow radiographic abnormalities in a patient with dermatomyositis and severe dysphagia after high-dose intravenous immunoglobulins. J Clin Rheumatol (2015) 0.75
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations. J Rheumatol Suppl (2014) 0.75
Cutaneous lesions as presenting symptoms of primary biliary cirrhosis: an undifferentiated connective tissue disease-like onset. Clin Rheumatol (2005) 0.75
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis. Clin Exp Rheumatol (2014) 0.75